Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Stocken · SciRah

Researcher profile · Semantic Scholar

D. Stocken

Share profile

D. Stocken — researcher profile on SciRah

h-index: 23
Works: 43
Citations: 9,779

Most-cited papers

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.
J. Neoptolemos, D. Stocken, H. Friess, C. Bassi +12 more
2004New England Journal of Medicine2,626 citations Open access
Semantic Scholar
Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial.
J. Neoptolemos, D. Stocken, C. Bassi, P. Ghaneh +23 more
2010Journal of the American Medical Association (JAMA)1,175 citations Open access
Semantic Scholar
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial.
J. Neoptolemos, J. Dunn, D. Stocken, J. Almond +13 more
2001The Lancet1,047 citations Open access
Semantic Scholar
Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer.
D. Cunningham, I. Chau, D. Stocken, J. Valle +16 more
2009Journal of Clinical Oncology750 citations Open access
Semantic Scholar
Influence of Resection Margins on Survival for Patients With Pancreatic Cancer Treated by Adjuvant Chemoradiation and/or Chemotherapy in the ESPAC-1 Randomized Controlled Trial
J. Neoptolemos, D. Stocken, J. Dunn, J. Almond +19 more
2001Annals of Surgery624 citations Open access
Semantic Scholar
Clinical and genetic characteristics of hereditary pancreatitis in Europe.
N. Howes, M. Lerch, W. Greenhalf, D. Stocken +14 more
2004Clinical Gastroenterology and Hepatology600 citations Open access
Semantic Scholar
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial.
T. Meyer, R. Fox, Yuk-Ting Ma, P. Ross +14 more
2017The Lancet Gastroenterology and Hepatology451 citations Open access
Semantic Scholar
Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study.
J. Valle, D. Palmer, R. Jackson, T. Cox +24 more
2014Journal of Clinical Oncology420 citations Open access
Semantic Scholar
Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer
D. Stocken, M. Büchler, C. Dervenis, C. Bassi +6 more
2004British Journal of Cancer355 citations Open access
Semantic Scholar
Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials.
G. Butturini, D. Stocken, M. Wente, H. Jeekel +8 more
2008Archives of Surgery329 citations Open access
Semantic Scholar
A Randomized Phase 2 Trial of Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer: Gemcitabine Alone Versus Gemcitabine Combined with Cisplatin
D. Palmer, D. Stocken, H. Hewitt, Catherine E. Markham +4 more
2007Annals of Surgical Oncology229 citations Open access
Semantic Scholar
Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials
J. Neoptolemos, D. Stocken, C. T. Smith, C. Bassi +7 more
2009British Journal of Cancer187 citations Open access
Semantic Scholar
Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study
J. Bridgewater, Peter Fletcher, D. Palmer, H. Malik +22 more
2022Journal of Clinical Oncology185 citations Open access
Semantic Scholar
Adjuvant therapy in pancreatic cancer: historical and current perspectives.
J. Neoptolemos, D. Cunningham, H. Friess, C. Bassi +9 more
2003Annals of Oncology142 citations Open access
Semantic Scholar
A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer
S. A. Hussain, D. Stocken, P. Riley, D. H. Palmer +4 more
2004British Journal of Cancer107 citations Open access
Semantic Scholar
ESPAC-3(v2): A multicenter, international, open-label, randomized controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma.
J. Neoptolemos, M. Büchler, D. Stocken, P. Ghaneh +6 more
2009Journal of Clinical Oncology96 citations
Semantic Scholar
Long-term results of a phase II study of synchronous chemoradiotherapy in advanced muscle invasive bladder cancer
S. Hussain, D. Stocken, D. Peake, J. Glaholm +3 more
2004British Journal of Cancer72 citations Open access
Semantic Scholar
The Value of Source Data Verification in a Cancer Clinical Trial
Catrin Tudur Smith, D. Stocken, J. Dunn, T. Cox +3 more
2012PLoS ONE68 citations Open access
Semantic Scholar
Influence of Surgical Resection and Post-Operative Complications on Survival following Adjuvant Treatment for Pancreatic Cancer in the ESPAC-1 Randomized Controlled Trial
C. Bassi, D. Stocken, A. Oláh, H. Friess +9 more
2006Digestive Surgery68 citations Open access
Semantic Scholar
Cationic trypsinogen mutations and pancreatitis.
N. Howes, W. Greenhalf, D. Stocken, J. Neoptolemos
2004Clinics in Laboratory Medicine50 citations
Semantic Scholar
Preoperative mitomycin, ifosfamide, and cisplatin followed by esophagectomy in squamous cell carcinoma of the esophagus: pathologic complete response induced by chemotherapy leads to long-term survival.
S. Darnton, V. Archer, D. Stocken, P. Mulholland +2 more
2003Journal of Clinical Oncology48 citations Open access
Semantic Scholar
Longitudinal quality of life data can provide insights on the impact of adjuvant treatment for pancreatic cancer—Subset analysis of the ESPAC‐1 data
R. Carter, D. Stocken, P. Ghaneh, S. Bramhall +8 more
2009International Journal of Cancer35 citations Open access
Semantic Scholar
A randomised controlled trial to evaluate both the role and the optimal fractionation of radiotherapy in the conservative management of early breast cancer.
D. Spooner, D. Stocken, S. Jordan, S. Bathers +6 more
2009Clinics in oncology32 citations Open access
Semantic Scholar
The case for adjuvant chemotherapy in pancreatic cancer.
P. Ghaneh, A. Sultana, S. Shore, D. Stocken +1 more
2006Best practice & research. Clinical gastroenterology20 citations Open access
Semantic Scholar
TACE 2: A randomized placebo-controlled, double-blinded, phase III trial evaluating sorafenib in combination with transarterial chemoembolisation (TACE) in patients with unresectable hepatocellular carcinoma (HCC).
T. Meyer, R. Fox, D. Bird, A. Watkinson +4 more
201215 citations
Semantic Scholar
A phase II irinotecan–cisplatin combination in advanced pancreatic cancer
Catherine E. Markham, D. Stocken, A. Hassan
2003British Journal of Cancer13 citations Open access
Semantic Scholar
[Adjuvant and additive therapy for cancer of the pancreas].
J. Neoptolemos, M. Raraty, P. Ghaneh, H. Hickey +4 more
2003Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen8 citations
Semantic Scholar
Combined results from three phase II trials of neoadjuvant chemotherapy in operable adenocarcinoma of the oesophagus.
V. Archer, P. Mulholland, D. Stocken, S. Darnton +1 more
2001Clinics in oncology8 citations Open access
Semantic Scholar
Cationic trypsinogen mutations and pancreatitis.
N. Howes, W. Greenhalf, D. Stocken, J. Neoptolemos
2005Gastroenterology Clinics of North America6 citations Open access
Semantic Scholar
A randomized phase II trial of neoadjuvant chemotherapy for patients with resectable pancreatic cancer: Gemcitabine alone vs. gemcitabine combined with cisplatin.
D. Palmer, D. Stocken, J. Buckels, H. Hewitt +5 more
2004Journal of Clinical Oncology6 citations Open access
Semantic Scholar
Adjuvante und additive Therapie beim Pankreaskarzinom
J. Neoptolemos, M. Raraty, P. Ghaneh, H. Hickey +4 more
2003Der Chirurg4 citations
Semantic Scholar
Meta-analysis of adjuvant chemoradiotherapy and chemotherapy for resectable pancreatic cancer including the final results of the ESPAC-1 trial
J. Neoptolemos, D. Stocken, J. Dunn, K. E. Bakkevold +2 more
19984 citations
Semantic Scholar
linical and Genetic Characteristics of Hereditary Pancreatitis n Europe
A. Howes, M. Lerch, W. Greenhalf, D. Stocken +14 more
20042 citations
Semantic Scholar
Six of the Best, Upper GI 14
J. Neoptolemos, D. Stocken, J. Dunn, J. Buckels +4 more
20091 citations
Semantic Scholar
Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer
D. Palmer, D. Stocken, H. Hewitt, Catherine E. Markham +4 more
2008Annals of Surgical Oncology1 citations
Semantic Scholar
EDS Society News
P. Kornprat, H. Mischinger, K. Fearon, J. Andersen +89 more
2006Digestive Surgery1 citations Open access
Semantic Scholar
Progress by Collaboration: ESPAC Studies
R. Sutton, D. Stocken, J. Dunn, H. Hickey +8 more
20041 citations
Semantic Scholar
Long-term results of a phase II study of synchronous chemo radiotherapy in muscle invasive bladder cancer.
S. Hussain, D. Stocken, D. Peake, J. Glaholm +3 more
2004Journal of Clinical Oncology1 citations
Semantic Scholar
Long Term Outcomes and Exploratory Analyses of the Randomised Phase 3 BILCAP Study
J. Bridgewater, Peter Fletcher, D. Palmer, Hassan Malik +22 more
2021Social Science Research Network0 citations
Semantic Scholar
A randomised placebo-controlled , double-blinded , phase 3 trial evaluating sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma
T. Meyer, R. Fox, Yuk-Ting Ma, P. Ross +17 more
20170 citations
Semantic Scholar
ESPAC-3(v2): A multicenter, international, open-label, randomized, controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma.
J. Neoptolemos, M. Büchler, D. Stocken, P. Ghaneh +6 more
2009Journal of Clinical Oncology0 citations
Semantic Scholar
Influence des marges de résection et du traitement sur la survie au cancer du pancréas
G. Butturini, D. Stocken, Moritz N. Wente, H. Jeekel +8 more
20080 citations
Semantic Scholar
2nd Hellenic Congress of the Hellenic Society for Digestive Surgery
P. Kornprat, H. Mischinger, K. Fearon, J. Andersen +89 more
2006Digestive Surgery0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Neoptolemos×20
Invite
J. Neoptolemos — researcher profile on SciRah
J. Dunn×15
Invite
J. Dunn — researcher profile on SciRah
P. Ghaneh×14
Invite
P. Ghaneh — researcher profile on SciRah
C. Bassi×13
Invite
C. Bassi — researcher profile on SciRah

×12

Invite

C. Dervenis — researcher profile on SciRah

Invite

H. Friess — researcher profile on SciRah

Invite

H. Hickey — researcher profile on SciRah

Invite

M. Büchler — researcher profile on SciRah

Invite

J. Buckels — researcher profile on SciRah

Invite

D. Palmer — researcher profile on SciRah

Invite

M. Büchler — researcher profile on SciRah

D. Cunningham×6

Invite

D. Cunningham — researcher profile on SciRah